Page 1443 - Hematology_ Basic Principles and Practice ( PDFDrive )

1287.e2 Part VII Hematologic Malignancies

43. Fischbach W, Goebeler-Kolve ME, Dragosics B, et al: Long term mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl
outcome of patients with gastric marginal zone B cell lymphoma of J Med 338:804, 1998.
mucosa associated lymphoid tissue (MALT) following exclusive Heli- 67. Isaacson PG, Chott A, Nakamura S, et al: Extranodal marginal zone
cobacter pylori eradication therapy: experience from a large prospective lymphoma of mucosa-associated lymhpoid tissue (MALT lymphoma).
series. Gut 53:34, 2004. In Swerdlow SH, Campo E, Harris NL, et al, editors: WHO classifica-
44. Lecuit M, Abachin E, Martin A, et al: Immunoproliferative small tion of tumours of haematopoietic and lymphoid tissues, Lyon, France,
intestinal disease associated with Campylobacter jejuni. N Engl J Med 2008, International Agency for Research on Cancer, p 185.
350:239, 2004. 68. Bain BJ: Dutcher bodies. Am J Hematol 84:589, 2009.
45. Chanudet E, Zhou Y, Bacon CM, et al: Chlamydia psittaci is vari- 69. Dickey W, Kenny BD, McConnell JB: Effect of proton pump inhibitors
ably associated with ocular adnexal MALT lymphoma in different on the detection of Helicobacter pylori in gastric biopsies. Aliment
geographical regions. J Pathol 209:344, 2006. Pharmacol Ther 10:289, 1996.
46. Daibata M, Nemoto Y, Togitani K, et al: Absence of Chlamydia psittaci 70. Graham DY, Opekun AR, Hammoud F, et al: Studies regarding the
in ocular adnexal lymphoma from Japanese patients. Br J Haematol mechanism of false negative urea breath tests with proton pump inhibi-
132:651, 2006. tors. Am J Gastroenterol 98:1005, 2003.
47. de Cremoux P, Subtil A, Ferreri AJ, et al: Re: Evidence for an association 71. Kwee I, Rancoita PM, Rinaldi A, et al: Genomic profiles of MALT
between Chlamydia psittaci and ocular adnexal lymphomas. J Natl lymphomas: variability across anatomical sites. Haematologica 96:1064,
Cancer Inst 98:365, 2006. 2011.
48. Ferreri AJ, Guidoboni M, Ponzoni M, et al: Evidence for an association 72. Murga Penas EM, Callet-Bauchu E, Ye H, et al: The t(14;18)(q32;q21)/
between Chlamydia psittaci and ocular adnexal lymphomas. J Natl IGH-MALT1 translocation in MALT lymphomas contains templated
Cancer Inst 96:586, 2004. nucleotide insertions and a major breakpoint region similar to follicular
49. Ferreri AJ, Ponzoni M, Guidoboni M, et al: Bacteria-eradicating therapy and mantle cell lymphoma. Blood 115:2214, 2010.
with doxycycline in ocular adnexal MALT lymphoma: a multicenter 73. Ho L, Davis RE, Conne B, et al: MALT1 and the API2-MALT1
prospective trial. J Natl Cancer Inst 98:1375, 2006. fusion act between CD40 and IKK and confer NF-kappa B-dependent
50. Ferreri AJ, Govi S, Pasini E, et al: Chlamydophila psittaci eradica- proliferative advantage and resistance against FAS-induced cell death in
tion with doxycycline as first-line targeted therapy for ocular adnexae B cells. Blood 105:2891, 2005.
lymphoma: final results of an international phase II trial. J Clin Oncol 74. Rosebeck S, Madden L, Jin X, et al: Cleavage of NIK by the API2-
30:2988, 2012. MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activa-
51. Gracia E, Froesch P, Mazzucchelli L, et al: Low prevalence of Chlamydia tion. Science 331:468, 2011.
psittaci in ocular adnexal lymphomas from Cuban patients. Leuk 75. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al: Resistance
Lymphoma 48:104, 2007. of t(11;18) positive gastric mucosa-associated lymphoid tissue lym-
52. Liu YC, Ohyashiki JH, Ito Y, et al: Chlamydia psittaci in ocular adnexal phoma to Helicobacter pylori eradication therapy. Lancet 357:39,
lymphoma: Japanese experience. Leuk Res 30:1587, 2006. 2001.
53. Mulder MM, Heddema ER, Pannekoek Y, et al: No evidence for an 76. Ye H, Liu H, Raderer M, et al: High incidence of t(11;18)(q21;q21) in
association of ocular adnexal lymphoma with Chlamydia psittaci in a Helicobacter pylori-negative gastric MALT lymphoma. Blood 101:2547,
cohort of patients from the Netherlands. Leuk Res 30:1305, 2006. 2003.
54. Rosado MF, Byrne GE, Jr, Ding F, et al: Ocular adnexal lymphoma: a 77. Rinaldi A, Mian M, Chigrinova E, et al: Genome-wide DNA profiling
clinicopathologic study of a large cohort of patients with no evidence of marginal zone lymphomas identifies subtype-specific lesions with an
for an association with Chlamydia psittaci. Blood 107:467, 2006. impact on the clinical outcome. Blood 117:1595, 2011.
55. Vargas RL, Fallone E, Felgar RE, et al: Is there an association between 78. Streubel B, Vinatzer U, Lamprecht A, et al: T(3;14)(p14.1;q32) involv-
ocular adnexal lymphoma and infection with Chlamydia psittaci? The ing IGH and FOXP1 is a novel recurrent chromosomal aberration in
University of Rochester experience. Leuk Res 30:547, 2006. MALT lymphoma. Leukemia 19:652, 2005.
56. Li C, Inagaki H, Kuo TT, et al: Primary cutaneous marginal zone B-cell 79. Honma K, Tsuzuki S, Nakagawa M, et al: TNFAIP3/A20 functions
lymphoma: a molecular and clinicopathologic study of 24 asian cases. as a novel tumor suppressor gene in several subtypes of non-Hodgkin
Am J Surg Pathol 27:1061, 2003. lymphomas. Blood 114:2467, 2009.
57. Wood GS, Kamath NV, Guitart J, et al: Absence of Borrelia burgdorferi 80. Novak U, Rinaldi A, Kwee I, et al: The NF-{kappa}B negative
DNA in cutaneous B-cell lymphomas from the United States. J Cutan regulator TNFAIP3 (A20) is inactivated by somatic mutations and
Pathol 28:502, 2001. genomic deletions in marginal zone lymphomas. Blood 113:4918,
58. Goodlad JR, Davidson MM, Hollowood K, et al: Primary cutaneous 2009.
B-cell lymphoma and Borrelia burgdorferi infection in patients from 81. Craig VJ, Arnold I, Gerke C, et al: Gastric MALT lymphoma B cells
the Highlands of Scotland. Am J Surg Pathol 24:1279, 2000. express polyreactive, somatically mutated immunoglobulins. Blood
59. Cerroni L, Zochling N, Putz B, et al: Infection by Borrelia burgdorferi 115:581, 2010.
and cutaneous B-cell lymphoma. J Cutan Pathol 24:457, 1997. 82. Seligmann M, Danon F, Hurez D, et al: Alpha-chain disease: a new
60. Anderson LA, Gadalla S, Morton LM, et al: Population-based study of immunoglobulin abnormality. Science 162:1396, 1968.
autoimmune conditions and the risk of specific lymphoid malignancies. 83. Malfertheiner P, Megraud F, O’Morain C, et al: Current concepts in
Int J Cancer 125:398, 2009. the management of Helicobacter pylori infection: the Maastricht III
61. Holm LE, Blomgren H, Lowhagen T: Cancer risks in patients with Consensus Report. Gut 56:772, 2007.
chronic lymphocytic thyroiditis. N Engl J Med 312:601, 1985. 84. Zullo A, Hassan C, Andriani A, et al: Eradication therapy for Helico-
62. Kato I, Tajima K, Suchi T, et al: Chronic thyroiditis as a risk factor of bacter pylori in patients with gastric MALT lymphoma: a pooled data
B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 76:1085, 1985. analysis. Am J Gastroenterol 104:1932, 2009.
63. Smedby KE, Hjalgrim H, Askling J, et al: Autoimmune and chronic 85. Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al: Proposal for a
inflammatory disorders and risk of non-Hodgkin lymphoma by new histological grading system for post-treatment evaluation of gastric
subtype. J Natl Cancer Inst 98:51, 2006. MALT lymphoma. Gut 52:1656, 2003.
64. Smedby KE, Vajdic CM, Falster M, et al: Autoimmune disorders and 86. Wundisch T, Mosch C, Neubauer A, et al: Helicobacter pylori eradica-
risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the tion in gastric mucosa-associated lymphoid tissue lymphoma: results of
InterLymph Consortium. Blood 111:4029, 2008. a 196-patient series. Leuk Lymphoma 47:2110, 2006.
65. Suarez F, Lortholary O, Hermine O, et al: Infection-associated lym- 87. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al: Most
phomas derived from marginal zone B cells: a model of antigen-driven patients with minimal histological residuals of gastric MALT lymphoma
lymphoproliferation. Blood 107:3034, 2006. after successful eradication of Helicobacter pylori can be managed safely
66. Zucca E, Bertoni F, Roggero E, et al: Molecular analysis of the by a watch and wait strategy: experience from a large international
progression from Helicobacter pylori-associated chronic gastritis to series. Gut 56:1685, 2007.